acc0601 |
ERK1 |
phosphorylation |
Tyr204 |
human |
Pancreas Cancer |
MIA PaCa-2 |
Erlotinib |
Negative |
5.0 |
33614917
|
acc0602 |
ERK2 |
phosphorylation |
Thr185 |
human |
Pancreas Cancer |
MIA PaCa-2 |
Erlotinib |
Negative |
5.0 |
33614917
|
acc0603 |
ERK2 |
phosphorylation |
Tyr187 |
human |
Pancreas Cancer |
MIA PaCa-2 |
Erlotinib |
Negative |
5.0 |
33614917
|
acc0604 |
AKT |
phosphorylation |
Ser473 |
human |
Pancreas Cancer |
MIA PaCa-2 |
Erlotinib |
Negative |
5.0 |
33614917
|
acc0605 |
ERK1 |
phosphorylation |
Thr202 |
human |
Pancreas Cancer |
BxPC-3 |
Erlotinib |
Negative |
5.0 |
33614917
|
acc0606 |
ERK1 |
phosphorylation |
Tyr204 |
human |
Pancreas Cancer |
BxPC-3 |
Erlotinib |
Negative |
5.0 |
33614917
|
acc0607 |
ERK2 |
phosphorylation |
Thr185 |
human |
Pancreas Cancer |
BxPC-3 |
Erlotinib |
Negative |
5.0 |
33614917
|
acc0608 |
ERK2 |
phosphorylation |
Tyr187 |
human |
Pancreas Cancer |
BxPC-3 |
Erlotinib |
Negative |
5.0 |
33614917
|
acc0609 |
ERK1 |
phosphorylation |
Thr202 |
human |
Pancreas Cancer |
PANC-1 |
Erlotinib |
Negative |
5.0 |
33614917
|
acc0610 |
ERK1 |
phosphorylation |
Tyr204 |
human |
Pancreas Cancer |
PANC-1 |
Erlotinib |
Negative |
5.0 |
33614917
|
acc0611 |
ERK2 |
phosphorylation |
Thr185 |
human |
Pancreas Cancer |
PANC-1 |
Erlotinib |
Negative |
5.0 |
33614917
|
acc0612 |
EGFR |
phosphorylation |
Tyr1068 |
human |
Ovarian Cancer |
A2780/DDP |
DDP |
Negative |
5.0 |
33794187
|
acc0613 |
EGFR |
phosphorylation |
Tyr1068 |
human |
Ovarian Cancer |
COC1/DDP |
DDP |
Negative |
5.0 |
33794187
|
acc0614 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Hepatocellular Carcinoma |
Hep3B |
FLLL32 |
Unresolved |
4.0 |
20818158
|
acc0615 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Hepatocellular Carcinoma |
SNU-398 |
FLLL32 |
Unresolved |
4.0 |
20818158
|
acc0616 |
EGFR |
phosphorylation |
Tyr1068 |
human |
Hepatocellular Carcinoma |
HepG2 |
Sorafenib + Berbamine + Ouabain |
Unresolved |
4.0 |
34233013
|
acc0617 |
Src |
phosphorylation |
Tyr416 |
human |
Hepatocellular Carcinoma |
HepG2 |
Sorafenib + Berbamine + Ouabain |
Unresolved |
4.0 |
34233013
|
acc0618 |
p38MAPK |
phosphorylation |
Tyr180 |
human |
Hepatocellular Carcinoma |
SK-HEP-1 |
Sorafenib + Berbamine + Ouabain |
Unresolved |
4.0 |
34233013
|
acc0619 |
p38MAPK |
phosphorylation |
Tyr182 |
human |
Hepatocellular Carcinoma |
SK-HEP-1 |
Sorafenib + Berbamine + Ouabain |
Unresolved |
4.0 |
34233013
|
acc0620 |
ERK1 |
phosphorylation |
Thr202 |
human |
Hepatocellular Carcinoma |
SK-HEP-1 |
Sorafenib + Berbamine + Ouabain |
Unresolved |
4.0 |
34233013
|
acc0621 |
ERK1 |
phosphorylation |
Tyr204 |
human |
Hepatocellular Carcinoma |
SK-HEP-1 |
Sorafenib + Berbamine + Ouabain |
Unresolved |
4.0 |
34233013
|
acc0622 |
ERK2 |
phosphorylation |
Thr185 |
human |
Hepatocellular Carcinoma |
SK-HEP-1 |
Sorafenib + Berbamine + Ouabain |
Unresolved |
4.0 |
34233013
|
acc0623 |
ERK2 |
phosphorylation |
Tyr187 |
human |
Hepatocellular Carcinoma |
SK-HEP-1 |
Sorafenib + Berbamine + Ouabain |
Unresolved |
4.0 |
34233013
|
acc0624 |
p38MAPK |
phosphorylation |
Tyr180 |
human |
Hepatocellular Carcinoma |
HepG2 |
Sorafenib + Berbamine + Ouabain |
Unresolved |
4.0 |
34233013
|
acc0625 |
p38MAPK |
phosphorylation |
Tyr182 |
human |
Hepatocellular Carcinoma |
HepG2 |
Sorafenib + Berbamine + Ouabain |
Unresolved |
4.0 |
34233013
|
acc0626 |
ERK1 |
phosphorylation |
Thr202 |
human |
Hepatocellular Carcinoma |
HepG2 |
Sorafenib + Berbamine + Ouabain |
Unresolved |
4.0 |
34233013
|
acc0627 |
ERK1 |
phosphorylation |
Tyr204 |
human |
Hepatocellular Carcinoma |
HepG2 |
Sorafenib + Berbamine + Ouabain |
Unresolved |
4.0 |
34233013
|
acc0628 |
ERK2 |
phosphorylation |
Thr185 |
human |
Hepatocellular Carcinoma |
HepG2 |
Sorafenib + Berbamine + Ouabain |
Unresolved |
4.0 |
34233013
|
acc0629 |
ERK2 |
phosphorylation |
Tyr187 |
human |
Hepatocellular Carcinoma |
HepG2 |
Sorafenib + Berbamine + Ouabain |
Unresolved |
4.0 |
34233013
|
acc0630 |
EGFR |
phosphorylation |
Tyr1068 |
human |
Hepatocellular Carcinoma |
SK-HEP-1 |
Sorafenib + Berbamine + Ouabain |
Unresolved |
4.0 |
34233013
|
acc0631 |
Src |
phosphorylation |
Tyr416 |
human |
Hepatocellular Carcinoma |
SK-HEP-1 |
Sorafenib + Berbamine + Ouabain |
Unresolved |
4.0 |
34233013
|
acc0632 |
ATR |
phosphorylation |
Ser/Thr |
human |
Gastric Cancer |
SUN638 |
Olaparib |
Negative |
5.0 |
34969765
|
acc0633 |
MAPK |
phosphorylation |
Thr180 |
human |
Gastric Cancer |
SUN638 |
Olaparib |
Negative |
5.0 |
34969765
|
acc0634 |
MAPK |
phosphorylation |
Tyr182 |
human |
Gastric Cancer |
SUN638 |
Olaparib |
Negative |
5.0 |
34969765
|
acc0635 |
Rock2 |
phosphorylation |
Ser1366 |
human |
Renal Cancer |
786-O |
Sunitinib |
Negative |
5.0 |
34974812
|
acc0636 |
Rock2 |
phosphorylation |
Ser1366 |
human |
Renal Cancer |
ACHN |
Sunitinib |
Negative |
5.0 |
34974812
|
acc0637 |
Rock2 |
phosphorylation |
Ser1366 |
human |
Renal Cancer |
786-O |
Everolimus |
Negative |
5.0 |
34974812
|
acc0638 |
Rock2 |
phosphorylation |
Ser1366 |
human |
Renal Cancer |
ACHN |
Everolimus |
Negative |
5.0 |
34974812
|
acc0639 |
JNK |
phosphorylation |
unclear |
human |
Ovarian Cancer |
A2780/DDP |
Cisplatin |
Positive |
5.0 |
35179434
|
acc0640 |
NT5C2 |
phosphorylation |
Ser502 |
human |
Leukemia |
Jurkat |
6-MP |
Negative |
5.0 |
35984649
|
acc0641 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Renal Cancer |
SK-RC-45 |
FLLL32 |
Unresolved |
4.0 |
22899991
|
acc0642 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Renal Cancer |
SK-RC-54 |
FLLL32 |
Unresolved |
4.0 |
22899991
|
acc0643 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Melanoma |
A375 |
FLLL32 |
Unresolved |
4.0 |
22899991
|
acc0644 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Melanoma |
Hs294T |
FLLL32 |
Unresolved |
4.0 |
22899991
|
acc0645 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Renal Cancer |
SK-RC-45 |
FLLL62 |
Unresolved |
4.0 |
22899991
|
acc0646 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Renal Cancer |
SK-RC-54 |
FLLL62 |
Unresolved |
4.0 |
22899991
|
acc0647 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Melanoma |
A375 |
FLLL62 |
Unresolved |
4.0 |
22899991
|
acc0648 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Melanoma |
Hs294T |
FLLL62 |
Unresolved |
4.0 |
22899991
|
acc0649 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Pancreas Cancer |
Paca44 |
Gemcitabine |
Negative |
5.0 |
24953430
|
acc0650 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Ovarian Cancer |
A1847 |
AZD1480 |
Unresolved |
4.0 |
25646015
|